Richard Payerchin

White House, HHS mull over new leadership for health care fraud enforcement.

New study outlines health care spending down to the county level.

Experts prescribe ways new administration immediately could bolster primary care.

Physicians are excited about the concepts of value-based payment models. So why do so many doctors stick with fee-for-service care?

New study outlines health care spending down to the county level.

Scorecard has bad marks for health care system that devotes rhetoric and attention — but not money — to primary care.

U.S. health care system gets failing grade for supporting primary care, say Milbank Memorial Fund and the Physicians Foundation.

Public benefit corporation announces developments for 2025.

Research estimates health care spending by conditions, age, types of care, down to county level.

Bargaining for widely used prescription drugs may save money for Medicare, but AAR wants seniors to see better prices at the pharmacy counter.

With high demand but high prices for antiobesity drugs, patients may fall for phony pharmaceuticals.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

House Ways and Means Committee considers suggestions on Making America Healthy Again.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

What new treatments mean for practices and patients.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Primary care, oncology can use team approach to improve prevention and screening efforts.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

A discussion about the Medicare Drug Price Negotiation Program with Adina Lasser, director of public policy and government affairs with the Alliance for Aging Research.

Congress could rectify the situation in upcoming spending bill or with pending legislation.

Legislators question Health and Human Services leaders about potential for wrongful disclosure of private health information.

Other clinicians and patients all have a place in slowing the spread of antimicrobial resistance.

Screenings are also crucial, but prior authorization requirements create a barrier to care.

Gallup, Emory University post findings about highest priorities for government leaders right now.

Agency logs national data for transition month between Biden and Trump administrations.

A family medicine specialist who works with cancer survivorship explains a study that shows how vital screenings are for patients.

An expert on antimicrobial resistance discusses how it involves patients in local doctors’ offices and around the world.